EyePoint Pharmaceuticals (NASDAQ: EYPT) reported Q1 EPS of ($0.99), $0.17 worse than the analyst estimate of ($0.82). Revenue for the quarter came in at $696 thousand versus the consensus estimate of $1.01 million.

For earnings history and earnings-related data on EyePoint Pharmaceuticals (EYPT) click here.